Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 10,457 | 13,467 | 4,119 | 9,795 | 6,145 |
| Gross Profit | 10,457 | 13,467 | 4,119 | 9,795 | 6,145 |
| Operating Expenses | 49,953 | 33,012 | 27,612 | 31,434 | 25,365 |
| Operating Income | -39,496 | -19,544 | -23,494 | -21,639 | -19,220 |
| Other Income | 3,356 | -46,539 | 3,781 | 6,334 | 1,581 |
| Pre-tax Income | -36,140 | -66,084 | -19,713 | -15,304 | -17,639 |
| Net Income Continuous | -36,140 | -66,084 | -19,713 | -15,304 | -17,639 |
| Minority Interests | -18 | -55 | -44 | -51 | -25 |
| Net Income | $-36,122 | $-66,029 | $-19,669 | $-15,253 | $-17,614 |
| EPS Basic Total Ops | -7.32 | -17.17 | -6.96 | -5.76 | -8.16 |
| EPS Basic Continuous Ops | -7.34 | -17.21 | -6.93 | -5.82 | -8.21 |
| EPS Diluted Total Ops | -7.68 | -17.17 | -6.96 | -5.76 | -8.16 |
| EPS Diluted Continuous Ops | -7.30 | -17.21 | -6.93 | -5.82 | -8.21 |
| EBITDA(a) | $-37,872 | $-17,446 | $-21,499 | $-19,627 | $-17,112 |